Patent ID: 11918559
Assignee: PRIMUS PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 13:
14. A solid oral pharmaceutical tablet consisting essentially of 640 mg of metaxalone and one or more pharmaceutically acceptable excipients, wherein:
a) the metaxalone consists essentially of from 40 to 80 wt % of a first grade of particles of metaxalone and from 20 to 60 wt % of a second grade of particles of metaxalone;
b) 90% of the first grade of particles of metaxalone are smaller than 100 microns when tested according to the Malvern Method; and
c) at least 35% of the second grade of particles of metaxalone are retained on a #120 sieve when tested by the Sieve Method.